T. Rowe Price Investment Management »

Xenon Pharmaceuticals shares owned by T. Rowe Price Investment Management

Quarter-by-quarter ownership of Xenon Pharmaceuticals (XENE) shares owned by T. Rowe Price Investment Management from 13F filings

Historical chart of T. Rowe Price Investment Management investment in Xenon Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Xenon Pharmaceuticals held by T. Rowe Price Investment Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Xenon Pharmaceuticals by T. Rowe Price Investment Management

Quarter filed Position value Share count Share price at filing
2024-03-31 $61M 1.4M 43.05

More positions owned by T. Rowe Price Investment Management

Microsoft Corp Comm Stk (MSFT)
Fortive Corp Comm Stk (FTV)
Alphabet Comm Stk (GOOGL)
Unitedhealth Group Comm Stk (UNH)
Amazon Comm Stk (AMZN)
Waste Connections Comm Stk (WCN)
PTC Comm Stk (PTC)
Ingersoll Rand Comm Stk (IR)
Microchip Technology Comm Stk (MCHP)
Canadian Nat Res Comm Stk (CNQ)
Becton Dickinson & Co Comm Stk (BDX)
Yum Brands Comm Stk (YUM)
Marvell Technology Comm Stk (MRVL)
Intercontinental Exchange In Comm Stk (ICE)
Revvity Comm Stk (RVTY)

View all positions for T. Rowe Price Investment Management

Top funds holding Xenon Pharmaceuticals

FMR
venBio Select Advisor
Wellington Management Company
Paradigm Biocapital Advisors
Commodore Capital
BlackRock
Adage Capital Partners GP
Alliancebernstein
Pictet Asset Management Holding SA
Marshall Wace
T. Rowe Price Investment Management
First Light Asset Management
Citadel Advisors
Braidwell
Rock Springs Capital Management

View all funds holding Xenon Pharmaceuticals